California school district informs parents period products are in bathrooms for 'any student who menstruates'
A California school district contacted parents via email on Thursday to let them know that all public schools containing grades 3 through 12 will have menstrual products in girls' bathrooms, all-gender bathrooms and at least one boys' bathroom.
California law previously required the same thing of all public schools that teach grades 6 through 12, but that order now extends to include schools with grades 3 through 5.
An email allegedly sent from the Long Beach Unified School District to parents, guardians and caregivers said the system is "committed to reducing barriers to learning and fostering a supportive environment for all students."
The availability of period products in girls' bathrooms and at least one boys' bathroom is to "ensure that any student who menstruates-including transgender boys and nonbinary students-can access these necessary products with dignity and discretion," per the email.
California Requires Menstrual Products In Public Schools
Long Beach USD asked for patience as dispensers are "currently being installed in restrooms across our school sites." It also encouraged families to discuss "appropriate and safe" use of period products with their children.
Read On The Fox News App
The email concluded with, "Thank you for your support in fostering a healthy, equitable and inclusive learning environment for all students."
Emerson College Adds Period Products To Men's Restrooms, Meeting Group's Demand For 'Menstrual Equality'
The "Menstrual Equality for All Act," which was passed in October 2023, said the changes must be enacted on or before the start of the 2024-2025 school year.
The following text was added to the state's education code when the bill was passed:
"On or before the start of the 2024–25 school year, a public school, including a school operated by a school district, county office of education, or charter school, maintaining any combination of classes from grades 3 to 12, inclusive, shall stock the school's restrooms at all times with an adequate supply of menstrual products, available and accessible, free of cost, in all women's restrooms and all-gender restrooms, and in at least one men's restroom."
Menstrual products were defined in the bill as pads and tampons specifically "for use in connection with the menstrual cycle."
The bill also said it is the state legislature's intent "to promote period equity through adequate access to menstrual products in schools also serving grades 3 to 5, inclusive."
Fox News Digital has reached out to the Long Beach Unified School District for comment.Original article source: California school district informs parents period products are in bathrooms for 'any student who menstruates'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Medical Terminology Software Outlook 2029: Key Trends, Vendor Insights, and Global Opportunities
Key growth drivers in the medical terminology software market include minimizing medical errors and the rising demand for terminology software. The report covers market size, trends, vendor analysis, and geographical segmentation, providing insights on the evolving market landscape for healthcare providers, payers, and IT vendors. Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Medical Terminology Software Market 2025-2029" has been added to offering. The medical terminology software market is poised for significant expansion, with projections indicating a growth of USD 3.80 billion from 2024 to 2029, at an impressive CAGR of 26.3%. This comprehensive report offers an in-depth analysis of market size and forecasts, emerging trends, growth drivers, and challenges, along with a detailed vendor analysis covering approximately 25 prominent vendors. The report presents a current market scenario, incorporating the latest insights on trends and drivers, and evaluates the overall market environment. The industry's growth is significantly driven by a heightened focus on reducing medical errors and a rising global demand for robust medical terminology software, fueled by discrepancies in terminology content worldwide. The analysis highlights the growing adoption of healthcare information technology as a significant growth area for the market. Additionally, the rise in medical tourism and increasing strategic alliances with new product launches are expected to create substantial market demand. The medical terminology software market segmentation includes: By End-user Healthcare providers Healthcare payers Healthcare IT vendors By Type Services Platforms By Application Data integration Data aggregation Reimbursement Clinical trials By Geographical Landscape North America Europe APAC South America Middle East and Africa Areas covered within the report: Medical Terminology Software Market sizing Medical Terminology Software Market forecast Medical Terminology Software Market industry analysis The report's robust vendor analysis is designed to help clients enhance their market position. Key players studied include: 3M Co. Apelon Inc. B2i Healthcare Pte Ltd. BITAC MAP SL BT Clinical Computing Clinical Architecture LLC Epic Systems Corp. Henry Schein Inc. HiveWorx Intelligent Medical Objects Inc. Medaara Healthcare Solutions Medocomp Systems Inc. Regenstrief Institute Rhapsody SNOMED International Spellex Corp. West Coast Informatics Wolters Kluwer NV Additionally, the report examines upcoming trends and challenges poised to influence market growth, offering strategic insights for leveraging future Topics Covered: Market Analysis Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Criticality of inputs and Factors of differentiation Factors of disruption Impact of drivers and challenges Market Landscape Market ecosystem Market characteristics Value chain analysis Market Sizing Market definition Market segment analysis Market size 2024 Market outlook: Forecast for 2024-2029 Historic Market Size Global Medical Terminology Software Market 2019 - 2023 End-user segment analysis 2019 - 2023 Type segment analysis 2019 - 2023 Application segment analysis 2019 - 2023 Geography segment analysis 2019 - 2023 Country segment analysis 2019 - 2023 Qualitative Analysis Impact of AI on Global Medical Terminology Software Market Five Forces Analysis Five forces summary Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition Market Segmentation by End-user Market segments Comparison by End-user Healthcare providers - Market size and forecast 2024-2029 Healthcare payers - Market size and forecast 2024-2029 Healthcare IT vendors - Market size and forecast 2024-2029 Market opportunity by End-user Market Segmentation by Type Market segments Comparison by Type Services - Market size and forecast 2024-2029 Platforms - Market size and forecast 2024-2029 Market opportunity by Type Market Segmentation by Application Market segments Comparison by Application Data integration - Market size and forecast 2024-2029 Data aggregation - Market size and forecast 2024-2029 Reimbursement - Market size and forecast 2024-2029 Clinical trials - Market size and forecast 2024-2029 Market opportunity by Application Customer Landscape Geographic Landscape Geographic segmentation Geographic comparison North America - Market size and forecast 2024-2029 Europe - Market size and forecast 2024-2029 APAC - Market size and forecast 2024-2029 South America - Market size and forecast 2024-2029 Middle East and Africa - Market size and forecast 2024-2029 Market opportunity By Geographical Landscape Drivers, Challenges, and Opportunity/Restraints Market drivers Market challenges Impact of drivers and challenges Market opportunities/restraints Competitive Landscape Competitive Landscape Landscape disruption Industry risks Competitive Analysis Companies profiled Company ranking index Market positioning of companies For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
Healthcare Simulation Market worth US$7.23 billion by 2030 with 15.6% CAGR
DELRAY BEACH, Fla., June 6, 2025 /PRNewswire/ -- The global Healthcare Simulation Market, valued at US$3.00 billion in 2024 stood at US$3.50 billion in 2025 and is projected to advance at a resilient CAGR of 15.6% from 2025 to 2030, culminating in a forecasted valuation of US$7.23 billion by the end of the period. This growth is likely to be driven by rising demand for standardized clinical training, increasing prevalence of chronic diseases, higher investment in healthcare technology, and more medical and nursing schools adopting simulation. Key contributors include patient simulators, interventional and cardiac surgical simulators, and simulation training services. Adoption is growing in hospitals and academic institutions, especially in North America and Asia Pacific. Governments are also supporting simulation-based training. For example, the University of Iowa received a USD 8-million grant from the Helmsley Charitable Trust to launch SIM-IA, a mobile simulation program for rural healthcare providers and first responders. Download PDF Brochure: Browse in-depth TOC on "Healthcare Simulation Market" 150 - Tables50 - Figures359 - Pages By Based on product & service, the healthcare simulation market, by product & service, is segmented into healthcare simulation anatomical models, healthcare simulation software, web-based simulation, and simulation training services. In 2024, the anatomical models accounted for the largest market share, driven by the increasing emphasis on patient safety and hands-on clinical training. These models allow medical students and professionals to practice procedures in a realistic, risk-free environment, enhancing clinical skills and reducing medical errors. As healthcare systems aim to improve efficiency and reduce costs, anatomical models are widely adopted as cost-effective alternatives to traditional training with live patients. Furthermore, the rising demand for minimally invasive procedures, ongoing advancements in surgical techniques, and growing funding for simulation-based education continue to boost their adoption in academic institutions and healthcare facilities, solidifying their position as the leading segment in the market. By Based on technology, the healthcare simulation market is segmented by technology into virtual patient simulation, 3D printing, and procedural rehearsal technology. Among these, the virtual patient simulation segment is expected to register the fastest growth rate during the forecast period due to its ability to provide immersive, risk-free, and repeatable training experiences for healthcare professionals. Leveraging virtual reality (VR) and augmented reality (AR) enables learners to practice clinical scenarios, decision-making, and patient interactions in highly realistic environments. This technology is particularly valuable for training in complex or rare medical cases that are difficult to encounter in real life. Several recent developments underscore this trend. For instance, in November 2024, VRAD Co., Ltd. launched NS_Core and IP_Trauma—two VR-based simulators for nursing and trauma care. Moreover, in July 2024, MediSim VR and KD Hospital opened India's first VR nurse training lab to enhance clinical skills through immersive simulation. These developments highlight the growing strategic focus on virtual patient simulation as a transformative tool in modern medical education and clinical training. By geography, in 2024, North America led the healthcare simulation market, mainly driven by sustained investments in mobile simulation technology and rural healthcare training. Notable initiatives include Washington State University's Mobile Simulation Program, launched in June 2024; the Simulation in Motion–Iowa (SIM-IA) program, launched in June 2022; and the Parkview Health Mobile Medical Training Lab (Indiana, USA), launched in May 2024. These programs are specifically designed to address the needs of underserved and rural communities, delivering high-fidelity simulation training directly to local healthcare providers. Such initiatives exemplify North America's commitment to expanding equitable access to simulation-based education. Furthermore, strong collaborations between academic institutions and healthcare systems, robust government support through initiatives such as the Health Resources and Services Administration (HRSA) grants, federal and state funding for mobile simulation units, and significant philanthropic funding have positioned North America as a global leader in healthcare simulation. These combined efforts enhance clinical preparedness, improve healthcare delivery, and ultimately strengthen patient outcomes across the region. Request Sample Pages : The key players functioning in the healthcare simulation market include CAE Inc. (Canada), Laerdal Medical (Norway), Gaumard Scientific Co. (US), Kyoto Kagaku (Japan), Limbs & Things (UK), Mentice AB (Sweden), Simulab Corporation (US), Simulaids (US), Intelligent Ultrasound Group PLC (UK), and Operative Experience Inc. (UK), and Surgical Science Sweden AB (Sweden), among others. CAE Inc. (Canada): CAE Inc. is a leader in simulation and training technologies, with a specialized Healthcare division offering high-fidelity patient simulators, ultrasound simulators, pediatric simulators, and surgical simulation systems. The company operates globally across 80+ countries, leveraging direct and partner-driven channels. CAE's core competencies include AR/VR integration, haptic feedback, and simulation center management. Major activities include strategic partnerships, acquisitions (e.g., Medicor), and R&D investments. CAE focuses on developing innovative training solutions, such as Vimedix and LucinaAR, and supports simulation research through collaborations with global universities, enhancing clinical skills and patient outcomes. Laerdal Medical (Norway) Laerdal Medical specializes in simulation-based training to improve patient outcomes, offering high-fidelity patient simulators, CPR manikins, and task trainers. The company's core competencies lie in scalable digital learning, resuscitation, and trauma care training. Major activities include acquisitions (e.g., B-Line Medical) and partnerships (e.g., SimX for VR simulation). Laerdal strongly focuses on innovation and adaptive learning, collaborating with global organizations such as the American Heart Association and GAVI. These initiatives enable Laerdal to lead in digital healthcare education and significantly advance clinical competency and patient safety. For more information, Inquire Now! Related Reports: Healthcare Education Market Healthcare Analytical Testing Services Market Healthcare IT Market Healthcare Analytics Market Remote Patient Monitoring Market Get access to the latest updates on Healthcare Simulation Companies and Healthcare Simulation Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Sign in to access your portfolio
Yahoo
8 hours ago
- Yahoo
Peripheral Neuropathy Treatment Market Landscape 2025-2029: Robust Drug Pipeline to Expand the Market by $481 Million
Key drivers include increased prevalence, new drug approvals, and rising awareness. The report offers comprehensive analysis, segmentation by type, therapy, and region, and a vendor landscape, aiding strategic insights. Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Peripheral Neuropathy Treatment Market 2025-2029" has been added to offering. The global peripheral neuropathy treatment market is projected to achieve significant growth, with an increase of USD 481.6 million anticipated from 2024 to 2029, advancing at a CAGR of 4.5% within the forecast period. This burgeoning market is comprehensively detailed in this report, offering insights into market size, forthcoming trends, growth drivers, challenges, and an extensive vendor evaluation including analysis of around 25 key industry participants. Central to this market's growth are driving factors such as the growing prevalence of peripheral neuropathy, a wave of recent drug approvals, and heightened public awareness. A significant growth driver is the robust drug pipeline, poised to expand the market in the coming years. In addition, technological advances leading to new drug formulations, along with increased research and development efforts, are expected to substantially boost demand in the market. The compilation of this report involved a meticulous blend of primary and secondary data sourced from significant industry contributors. As a result, the report serves up comprehensive market size data, detailed segmentation including regional breakdowns, a vendor landscape appraisal, and assessments of key companies. This is bolstered by historic and forecast data for nuanced insight. The peripheral neuropathy treatment market is segmented as follows: By Type: Diabetic Chemotherapy Others By Therapy: Pharmacological therapies Non-pharmacological therapies By Diagnostic Methods: Blood test Biopsy Imaging By End-user: Hospitals and clinics Retail pharmacy Online pharmacy By Geographical Landscape: North America Europe Asia Rest of World (RoW) The report explores the diverse areas within the peripheral neuropathy treatment market including market sizing, forecasting, and industry analysis. Under a robust vendor analysis framework, the report aids clients in refining their market position by providing an in-depth evaluation of prominent vendors. Additionally, it includes foresight into emerging trends and potential challenges influencing future market growth, enabling companies to strategize effectively. With a detailed synthesis of data from multiple origins examined using essential parameters like profit, pricing, competition, and promotions, the report conveys a comprehensive market narrative. It identifies pivotal industry influencers and presents highly credible data derived from extensive primary and secondary research. The comprehensive market research report offers an exhaustive competitive landscape and detailed vendor selection methodology, employing a blend of qualitative and quantitative research to ensure precise growth forecasts. A selection of companies mentioned in this report includes, but is not limited to: Apotex Inc. ASSERTIO HOLDINGS INC. AstraZeneca Plc Cadila Pharmaceuticals Ltd. Cipla Inc. Daiichi Sankyo Co. Ltd. Dr Reddys Laboratories Ltd. Eli Lilly and Co. Endo International PLC Grunenthal GmbH Hikma Pharmaceuticals PLC Johnson and Johnson Services Inc. Lupin Ltd. Novartis AG Pfizer Inc. SHIONOGI Co. Ltd. Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. UCB SA Viatris Inc. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900